SecFilingDex

AEON Biopharma, Inc.

4 SEC EDGAR filings indexed (CIK 0001837607) across 4 form types.

Filing profile

AEON Biopharma, Inc. (AEON) has 4 SEC filings indexed on SecFilingDex, across 4 form types, from September 30, 2026 to November 10, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).

Its most frequent disclosure is the SC 13D/A (5%+ activist stake) with 1 filing — Disclosure of beneficial ownership above 5% with intent to influence company control. 4 of these filings were disclosed in the twelve months to November 10, 2026. 1 of the 4 is an amendment (a corrected or updated version of an earlier filing).

Disclosure mix

  • 1SC 13D/A5%+ activist stake · event-driven (within 10 days)
  • 1424B3Updated prospectus · event-driven
  • 1DEF 14AProxy statement · annual (pre-meeting)
  • 18-KMaterial event · event-driven

Profile derived from 4 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1837607&type=&dateb=&owner=include&count=40 ↗

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.